A joint model of persistent human papilloma virus infection and cervical cancer risk: Implications for cervical cancer screening

Hormuzd A. Katki, Li C. Cheung, Barbara Fetterman, Philip E. Castle, Rajeshwari Sundaram

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

New cervical cancer screening guidelines in the USA and many European countries recommend that women are tested for human papilloma virus (HPV). To inform decisions about screening intervals, we calculate the increase in precancer or cancer risk per year of continued HPV infection. However, both time to onset of precancer or cancer and time to HPV clearance are interval censored, and onset of precancer or cancer strongly informatively censors HPV clearance. We analyse these bivariate informatively interval-censored data by developing a novel joint model for time to clearance of HPV and time to precancer or cancer by using shared random effects, where the estimated mean duration of each woman's HPV infection is a covariate in the submodel for time to precancer or cancer. The model was fitted to data on 9553 HPV positive and negative women undergoing cervical cancer screening at Kaiser Permanente Northern California: data that were pivotal to the development of US screening guidelines. We compare the implications for screening intervals of this joint model with those from population-average marginal models of precancer or cancer risk. In particular, after 2 years the marginal population-average precancer or cancer risk was 5%, suggesting a 2-year interval to control population-average risk at 5%. In contrast, the joint model reveals that almost all women exceeding 5% individual risk in 2 years also exceeded 5% in 1 year, suggesting that a 1-year interval is better to control individual risk at 5%. The example suggests that sophisticated risk models that can predict individual risk may have implications that are different from those of population-average risk models that are currently used for informing medical guideline development.

Original languageEnglish (US)
Pages (from-to)903-923
Number of pages21
JournalJournal of the Royal Statistical Society. Series A: Statistics in Society
Volume178
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Joint Model
Virus
Screening
Infection
Cancer
cancer
Clearance
Interval
Human
Cancer screening
Cervical cancer
Interval-censored Data
Marginal Model
Random Effects
Covariates
time
Model
Calculate
Predict
Individual risk

Keywords

  • Cancer screening
  • Human papilloma virus
  • Joint modelling of longitudinal and survival data
  • Medical guidelines
  • Risk modelling

ASJC Scopus subject areas

  • Statistics and Probability
  • Social Sciences (miscellaneous)
  • Economics and Econometrics
  • Statistics, Probability and Uncertainty

Cite this

A joint model of persistent human papilloma virus infection and cervical cancer risk : Implications for cervical cancer screening. / Katki, Hormuzd A.; Cheung, Li C.; Fetterman, Barbara; Castle, Philip E.; Sundaram, Rajeshwari.

In: Journal of the Royal Statistical Society. Series A: Statistics in Society, Vol. 178, No. 4, 01.10.2015, p. 903-923.

Research output: Contribution to journalArticle

@article{a3748ca153af447cac0f0353cb573541,
title = "A joint model of persistent human papilloma virus infection and cervical cancer risk: Implications for cervical cancer screening",
abstract = "New cervical cancer screening guidelines in the USA and many European countries recommend that women are tested for human papilloma virus (HPV). To inform decisions about screening intervals, we calculate the increase in precancer or cancer risk per year of continued HPV infection. However, both time to onset of precancer or cancer and time to HPV clearance are interval censored, and onset of precancer or cancer strongly informatively censors HPV clearance. We analyse these bivariate informatively interval-censored data by developing a novel joint model for time to clearance of HPV and time to precancer or cancer by using shared random effects, where the estimated mean duration of each woman's HPV infection is a covariate in the submodel for time to precancer or cancer. The model was fitted to data on 9553 HPV positive and negative women undergoing cervical cancer screening at Kaiser Permanente Northern California: data that were pivotal to the development of US screening guidelines. We compare the implications for screening intervals of this joint model with those from population-average marginal models of precancer or cancer risk. In particular, after 2 years the marginal population-average precancer or cancer risk was 5{\%}, suggesting a 2-year interval to control population-average risk at 5{\%}. In contrast, the joint model reveals that almost all women exceeding 5{\%} individual risk in 2 years also exceeded 5{\%} in 1 year, suggesting that a 1-year interval is better to control individual risk at 5{\%}. The example suggests that sophisticated risk models that can predict individual risk may have implications that are different from those of population-average risk models that are currently used for informing medical guideline development.",
keywords = "Cancer screening, Human papilloma virus, Joint modelling of longitudinal and survival data, Medical guidelines, Risk modelling",
author = "Katki, {Hormuzd A.} and Cheung, {Li C.} and Barbara Fetterman and Castle, {Philip E.} and Rajeshwari Sundaram",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/rssa.12101",
language = "English (US)",
volume = "178",
pages = "903--923",
journal = "Journal of the Royal Statistical Society. Series A: Statistics in Society",
issn = "0964-1998",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - A joint model of persistent human papilloma virus infection and cervical cancer risk

T2 - Implications for cervical cancer screening

AU - Katki, Hormuzd A.

AU - Cheung, Li C.

AU - Fetterman, Barbara

AU - Castle, Philip E.

AU - Sundaram, Rajeshwari

PY - 2015/10/1

Y1 - 2015/10/1

N2 - New cervical cancer screening guidelines in the USA and many European countries recommend that women are tested for human papilloma virus (HPV). To inform decisions about screening intervals, we calculate the increase in precancer or cancer risk per year of continued HPV infection. However, both time to onset of precancer or cancer and time to HPV clearance are interval censored, and onset of precancer or cancer strongly informatively censors HPV clearance. We analyse these bivariate informatively interval-censored data by developing a novel joint model for time to clearance of HPV and time to precancer or cancer by using shared random effects, where the estimated mean duration of each woman's HPV infection is a covariate in the submodel for time to precancer or cancer. The model was fitted to data on 9553 HPV positive and negative women undergoing cervical cancer screening at Kaiser Permanente Northern California: data that were pivotal to the development of US screening guidelines. We compare the implications for screening intervals of this joint model with those from population-average marginal models of precancer or cancer risk. In particular, after 2 years the marginal population-average precancer or cancer risk was 5%, suggesting a 2-year interval to control population-average risk at 5%. In contrast, the joint model reveals that almost all women exceeding 5% individual risk in 2 years also exceeded 5% in 1 year, suggesting that a 1-year interval is better to control individual risk at 5%. The example suggests that sophisticated risk models that can predict individual risk may have implications that are different from those of population-average risk models that are currently used for informing medical guideline development.

AB - New cervical cancer screening guidelines in the USA and many European countries recommend that women are tested for human papilloma virus (HPV). To inform decisions about screening intervals, we calculate the increase in precancer or cancer risk per year of continued HPV infection. However, both time to onset of precancer or cancer and time to HPV clearance are interval censored, and onset of precancer or cancer strongly informatively censors HPV clearance. We analyse these bivariate informatively interval-censored data by developing a novel joint model for time to clearance of HPV and time to precancer or cancer by using shared random effects, where the estimated mean duration of each woman's HPV infection is a covariate in the submodel for time to precancer or cancer. The model was fitted to data on 9553 HPV positive and negative women undergoing cervical cancer screening at Kaiser Permanente Northern California: data that were pivotal to the development of US screening guidelines. We compare the implications for screening intervals of this joint model with those from population-average marginal models of precancer or cancer risk. In particular, after 2 years the marginal population-average precancer or cancer risk was 5%, suggesting a 2-year interval to control population-average risk at 5%. In contrast, the joint model reveals that almost all women exceeding 5% individual risk in 2 years also exceeded 5% in 1 year, suggesting that a 1-year interval is better to control individual risk at 5%. The example suggests that sophisticated risk models that can predict individual risk may have implications that are different from those of population-average risk models that are currently used for informing medical guideline development.

KW - Cancer screening

KW - Human papilloma virus

KW - Joint modelling of longitudinal and survival data

KW - Medical guidelines

KW - Risk modelling

UR - http://www.scopus.com/inward/record.url?scp=84942337366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942337366&partnerID=8YFLogxK

U2 - 10.1111/rssa.12101

DO - 10.1111/rssa.12101

M3 - Article

AN - SCOPUS:84942337366

VL - 178

SP - 903

EP - 923

JO - Journal of the Royal Statistical Society. Series A: Statistics in Society

JF - Journal of the Royal Statistical Society. Series A: Statistics in Society

SN - 0964-1998

IS - 4

ER -